Market Insights Health Medical Technology

Medical Devices - France

France

In 2024, the projected revenue in the Medical Devices market market in France is expected to reach €16.50bn.
Among the various markets, Cardiology_Devices is the largest, with a projected market volume of €2.33bn in the same year.
Looking ahead, the market is expected to experience a steady annual growth rate of 4.10% from 2024 to 2029 (CAGR 2024-2029), resulting in a market volume of €20.17bn by 2029.
It is worth noting that in the global market, the United States is anticipated to generate the highest revenue, amounting to €167.80bn in 2024.
France is leading the way in the development and adoption of innovative medical devices in the field of neurology.

Key regions: Germany, Spain, Japan, United Kingdom, United States

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Medical Devices market in France is experiencing steady growth due to several factors.

Customer preferences: Customers in France have a strong preference for high-quality medical devices that are reliable and efficient. They also value devices that are user-friendly and easy to operate. Additionally, there is a growing demand for innovative and technologically advanced medical devices that can improve patient outcomes and provide more accurate diagnoses.

Trends in the market: One of the key trends in the Medical Devices market in France is the increasing adoption of digital health technologies. This includes wearable devices, remote monitoring systems, and mobile health applications. These technologies enable patients to monitor their health conditions more effectively and allow healthcare professionals to remotely monitor patients and provide timely interventions. The COVID-19 pandemic has further accelerated the adoption of digital health technologies, as telemedicine and remote patient monitoring became crucial in ensuring continuity of care. Another trend in the market is the growing focus on personalized medicine. Advances in genomics and molecular diagnostics have paved the way for targeted therapies and personalized treatment plans. This has led to an increased demand for medical devices that can support precision medicine, such as genetic testing kits and companion diagnostics.

Local special circumstances: France has a well-established healthcare system that provides universal coverage to its citizens. This ensures that a large portion of the population has access to medical devices and healthcare services. The government also plays a significant role in the Medical Devices market through regulations and reimbursement policies. The French regulatory framework ensures that medical devices meet strict safety and quality standards before they can be marketed and sold in the country.

Underlying macroeconomic factors: The growth of the Medical Devices market in France is also influenced by macroeconomic factors. The country has a stable economy and a high level of healthcare expenditure, which supports the demand for medical devices. Additionally, France has an aging population, which is driving the demand for medical devices that cater to the needs of elderly patients. The increasing prevalence of chronic diseases, such as cardiovascular diseases and diabetes, also contributes to the growth of the market. In conclusion, the Medical Devices market in France is experiencing growth due to customer preferences for high-quality and innovative devices, the adoption of digital health technologies, the focus on personalized medicine, the well-established healthcare system, and underlying macroeconomic factors. These factors create a favorable environment for the development and expansion of the market in France.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.